Trial Outcomes & Findings for Behavioral Effects of Drugs (Inpatient): 38 (NCT NCT03954938)

NCT ID: NCT03954938

Last Updated: 2024-05-23

Results Overview

The reinforcing effects of cocaine were determined using a modified progressive ratio procedure (Stoops et al., 2010) in which subjects can make 5 choices for each available cocaine dose. Reinforcing effects were measured for each cocaine dose during across the craving manipulation conditions.

Recruitment status

TERMINATED

Study phase

EARLY_PHASE1

Target enrollment

5 participants

Primary outcome timeframe

One test for each of the craving manipulations for placebo and each cocaine dose level over approximately two weeks of participation.

Results posted on

2024-05-23

Participant Flow

This is a 3x3 fully factorial crossover study with 9 conditions tested in random order in each completing subject. The factors are cocaine dose (0, 40, 80 mg) and craving manipulation (positive \[anticipate positive aspects of consuming cocaine\], negative \[anticipate negative aspects of consuming cocaine\], neutral \[respond naturally\]). Each of these conditions was combined (e.g., 0 mg cocaine with positive craving manipulation).

Participant milestones

Participant milestones
Measure
BED IN 38
Within subjects study assessing three craving manipulations and three cocaine doses.
Overall Study
STARTED
5
Overall Study
Positive-80 mg Cocaine
5
Overall Study
Look-80 mg Cocaine
5
Overall Study
Positive-40 mg Cocaine
4
Overall Study
Look-0 mg Cocaine
4
Overall Study
Positive-0 mg Cocaine
3
Overall Study
Look-40 mg Cocaine
3
Overall Study
Negative-0 mg Cocaine
3
Overall Study
Negative-40 mg Cocaine
3
Overall Study
Negative-80 mg Cocaine
2
Overall Study
COMPLETED
2
Overall Study
NOT COMPLETED
3

Reasons for withdrawal

Reasons for withdrawal
Measure
BED IN 38
Within subjects study assessing three craving manipulations and three cocaine doses.
Overall Study
Withdrawal by Subject
2
Overall Study
Adverse Event
1

Baseline Characteristics

Behavioral Effects of Drugs (Inpatient): 38

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Completing Subjects
n=2 Participants
Subjects who completed the full study (i.e., completed all craving induction and cocaine dose conditions)
Age, Continuous
51.5 years
STANDARD_DEVIATION 3.54 • n=5 Participants
Sex: Female, Male
Female
0 Participants
n=5 Participants
Sex: Female, Male
Male
2 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
2 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
2 Participants
n=5 Participants
Race (NIH/OMB)
White
0 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Region of Enrollment
United States
2 participants
n=5 Participants

PRIMARY outcome

Timeframe: One test for each of the craving manipulations for placebo and each cocaine dose level over approximately two weeks of participation.

Population: Completing Subjects; Only data from completing subjects included due to within subjects design of the project.

The reinforcing effects of cocaine were determined using a modified progressive ratio procedure (Stoops et al., 2010) in which subjects can make 5 choices for each available cocaine dose. Reinforcing effects were measured for each cocaine dose during across the craving manipulation conditions.

Outcome measures

Outcome measures
Measure
Neutral-Look-0 mg Cocaine
n=2 Participants
Subjects were instructed to look at cocaine associated images and respond naturally. Craving Manipulation: Craving was manipulated based on instructions about cocaine associated images shown to subjects. Placebo: The reinforcing effects of placebo were determined based on the craving manipulation condition.
Positive-0 mg Cocaine
n=2 Participants
Subjects were instructed to look at cocaine associated images and anticipate the positive aspects of engaging with the items shown. Craving Manipulation: Craving was manipulated based on instructions about cocaine associated images shown to subjects. Placebo: The reinforcing effects of placebo were determined based on the craving manipulation condition.
Negative-0 mg Cocaine
n=2 Participants
Subjects were instructed to look at cocaine associated images and anticipate the negative aspects of engaging with the items shown. Craving Manipulation: Craving was manipulated based on instructions about cocaine associated images shown to subjects. Placebo: The reinforcing effects of placebo were determined based on the craving manipulation condition. Placebo: The pharmacodynamic effects of placebo will be determined based on the craving manipulation condition.
Neutral-Look-40 mg Cocaine
n=2 Participants
Subjects were instructed to look at cocaine associated images and respond naturally. Craving Manipulation: Craving was manipulated based on instructions about cocaine associated images shown to subjects. Cocaine: The reinforcing effects of 40 mg cocaine were determined based on the craving manipulation condition.
Positive-40 mg Cocaine
n=2 Participants
Subjects were instructed to look at cocaine associated images and anticipate the positive aspects of engaging with the items shown. Craving Manipulation: Craving was manipulated based on instructions about cocaine associated images shown to subjects. Cocaine: The reinforcing effects of 40 mg cocaine were determined based on the craving manipulation condition
Negative-40 mg Cocaine
n=2 Participants
Subjects were instructed to look at cocaine associated images and anticipate the negative aspects of engaging with the items shown. Craving Manipulation: Craving was manipulated based on instructions about cocaine associated images shown to subjects. Cocaine: The reinforcing effects of 40 mg cocaine were determined based on the craving manipulation condition
Neutral-Look-80 mg Cocaine
n=2 Participants
Subjects were instructed to look at cocaine associated images and respond naturally. Craving Manipulation: Craving was manipulated based on instructions about cocaine associated images shown to subjects. Cocaine: The reinforcing effects of 80 mg cocaine were determined based on the craving manipulation condition.
Positive-80 mg Cocaine
n=2 Participants
Subjects were instructed to look at cocaine associated images and anticipate the positive aspects of engaging with the items shown. Craving Manipulation: Craving was manipulated based on instructions about cocaine associated images shown to subjects. Cocaine: The reinforcing effects of 80 mg cocaine were determined based on the craving manipulation condition
Negative-80 mg Cocaine
n=2 Participants
Subjects were instructed to look at cocaine associated images and anticipate the negative aspects of engaging with the items shown. Craving Manipulation: Craving was manipulated based on instructions about cocaine associated images shown to subjects. Cocaine: The reinforcing effects of 80 mg cocaine were determined based on the craving manipulation condition
Number of Times Cocaine Was Selected
0 Times Cocaine Selected
Standard Error 0
0 Times Cocaine Selected
Standard Error 0
0 Times Cocaine Selected
Standard Error 0
1.5 Times Cocaine Selected
Standard Error 1.5
1 Times Cocaine Selected
Standard Error 1
1.5 Times Cocaine Selected
Standard Error 0.5
1 Times Cocaine Selected
Standard Error 1
2 Times Cocaine Selected
Standard Error 2
2 Times Cocaine Selected
Standard Error 0

SECONDARY outcome

Timeframe: Measured for each of the craving manipulations for placebo and each cocaine dose level over approximately two weeks of participation.

Population: Completing Subjects; Only data from completing subjects analyzed due to within subjects design of the project.

Cocaine craving was assessed using a 10 point craving questionnaire that asks subjects to rate how much they are craving cocaine at that moment. The minimum craving score is 0 (i.e., no craving), the maximum craving score is 10 (i.e., highest craving).

Outcome measures

Outcome measures
Measure
Neutral-Look-0 mg Cocaine
n=2 Participants
Subjects were instructed to look at cocaine associated images and respond naturally. Craving Manipulation: Craving was manipulated based on instructions about cocaine associated images shown to subjects. Placebo: The reinforcing effects of placebo were determined based on the craving manipulation condition.
Positive-0 mg Cocaine
n=2 Participants
Subjects were instructed to look at cocaine associated images and anticipate the positive aspects of engaging with the items shown. Craving Manipulation: Craving was manipulated based on instructions about cocaine associated images shown to subjects. Placebo: The reinforcing effects of placebo were determined based on the craving manipulation condition.
Negative-0 mg Cocaine
n=2 Participants
Subjects were instructed to look at cocaine associated images and anticipate the negative aspects of engaging with the items shown. Craving Manipulation: Craving was manipulated based on instructions about cocaine associated images shown to subjects. Placebo: The reinforcing effects of placebo were determined based on the craving manipulation condition. Placebo: The pharmacodynamic effects of placebo will be determined based on the craving manipulation condition.
Neutral-Look-40 mg Cocaine
n=2 Participants
Subjects were instructed to look at cocaine associated images and respond naturally. Craving Manipulation: Craving was manipulated based on instructions about cocaine associated images shown to subjects. Cocaine: The reinforcing effects of 40 mg cocaine were determined based on the craving manipulation condition.
Positive-40 mg Cocaine
n=2 Participants
Subjects were instructed to look at cocaine associated images and anticipate the positive aspects of engaging with the items shown. Craving Manipulation: Craving was manipulated based on instructions about cocaine associated images shown to subjects. Cocaine: The reinforcing effects of 40 mg cocaine were determined based on the craving manipulation condition
Negative-40 mg Cocaine
n=2 Participants
Subjects were instructed to look at cocaine associated images and anticipate the negative aspects of engaging with the items shown. Craving Manipulation: Craving was manipulated based on instructions about cocaine associated images shown to subjects. Cocaine: The reinforcing effects of 40 mg cocaine were determined based on the craving manipulation condition
Neutral-Look-80 mg Cocaine
n=2 Participants
Subjects were instructed to look at cocaine associated images and respond naturally. Craving Manipulation: Craving was manipulated based on instructions about cocaine associated images shown to subjects. Cocaine: The reinforcing effects of 80 mg cocaine were determined based on the craving manipulation condition.
Positive-80 mg Cocaine
n=2 Participants
Subjects were instructed to look at cocaine associated images and anticipate the positive aspects of engaging with the items shown. Craving Manipulation: Craving was manipulated based on instructions about cocaine associated images shown to subjects. Cocaine: The reinforcing effects of 80 mg cocaine were determined based on the craving manipulation condition
Negative-80 mg Cocaine
n=2 Participants
Subjects were instructed to look at cocaine associated images and anticipate the negative aspects of engaging with the items shown. Craving Manipulation: Craving was manipulated based on instructions about cocaine associated images shown to subjects. Cocaine: The reinforcing effects of 80 mg cocaine were determined based on the craving manipulation condition
Cocaine Craving
1.5 units on a 10 point scale
Standard Error .5
1 units on a 10 point scale
Standard Error 1
.5 units on a 10 point scale
Standard Error .5
1.5 units on a 10 point scale
Standard Error .5
2.5 units on a 10 point scale
Standard Error .5
1.5 units on a 10 point scale
Standard Error .5
1 units on a 10 point scale
Standard Error 0
3 units on a 10 point scale
Standard Error 1
1.5 units on a 10 point scale
Standard Error .5

Adverse Events

Positive-0 mg Cocaine

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Positive-40 mg Cocaine

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Positive-80 mg Cocaine

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Look-0 mg Cocaine

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Look-40 mg Cocaine

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Look-80 mg Cocaine

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Negative-0 mg Cocaine

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Negative-40 mg Cocaine

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Negative-80 mg Cocaine

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Positive-0 mg Cocaine
n=3 participants at risk
Participants instructed to respond positively to cocaine images and receive 0 mg cocaine
Positive-40 mg Cocaine
n=4 participants at risk
Participants instructed to respond positively to cocaine images and receive 40 mg cocaine
Positive-80 mg Cocaine
n=5 participants at risk
Participants instructed to respond positively to cocaine images and receive 80 mg cocaine
Look-0 mg Cocaine
n=4 participants at risk
Participants instructed to respond naturally to cocaine images and receive 0 mg cocaine
Look-40 mg Cocaine
n=3 participants at risk
Participants instructed to respond naturally to cocaine images and receive 40 mg cocaine
Look-80 mg Cocaine
n=5 participants at risk
Participants instructed to respond naturally to cocaine images and receive 80 mg cocaine
Negative-0 mg Cocaine
n=3 participants at risk
Participants instructed to respond negatively to cocaine images and receive 0 mg cocaine
Negative-40 mg Cocaine
n=3 participants at risk
Participants instructed to respond negatively to cocaine images and receive 40 mg cocaine
Negative-80 mg Cocaine
n=2 participants at risk
Participants instructed to respond negatively to cocaine images and receive 80 mg cocaine
Cardiac disorders
Tachycardia
0.00%
0/3 • Two weeks of study participation
This is a crossover, factorial study in which all subjects were randomly assigned to experience 9 conditions in random order.
0.00%
0/4 • Two weeks of study participation
This is a crossover, factorial study in which all subjects were randomly assigned to experience 9 conditions in random order.
0.00%
0/5 • Two weeks of study participation
This is a crossover, factorial study in which all subjects were randomly assigned to experience 9 conditions in random order.
0.00%
0/4 • Two weeks of study participation
This is a crossover, factorial study in which all subjects were randomly assigned to experience 9 conditions in random order.
0.00%
0/3 • Two weeks of study participation
This is a crossover, factorial study in which all subjects were randomly assigned to experience 9 conditions in random order.
0.00%
0/5 • Two weeks of study participation
This is a crossover, factorial study in which all subjects were randomly assigned to experience 9 conditions in random order.
0.00%
0/3 • Two weeks of study participation
This is a crossover, factorial study in which all subjects were randomly assigned to experience 9 conditions in random order.
0.00%
0/3 • Two weeks of study participation
This is a crossover, factorial study in which all subjects were randomly assigned to experience 9 conditions in random order.
50.0%
1/2 • Number of events 1 • Two weeks of study participation
This is a crossover, factorial study in which all subjects were randomly assigned to experience 9 conditions in random order.

Additional Information

William W. Stoops

University of Kentucky

Phone: 8592575388

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place